Resultados de la búsqueda 141-150 of 3691 for charcoal-activated-oral-route
Patients will be randomized in a 1:1 ratio to receive either alectinib, 600 mg orally twice daily (BID), or critozinib, 250 mg orally BID. Patients will receive ...
... activation and inflammation in surgical cases born preterm (<37 ... The purposes of this study are to determine whether maternal T cells are activated ...
This randomized, active ... Patients randomized to GDC-0199+R will be given GDC-0199 daily (oral ... activation and exhaustion. Numeración de páginas ...
A "Registry" is a list of basic information about people who have a certain disease or condition in common. These immune deficiency diseases are thought to be ...
The purpose of this study is to evaluate the impact of the location of SQ Nivo administration, at the infusion center or in the home, on patient preference ...
Patients randomized to GDC-0199+R will be given GDC-0199 daily (oral, target dose 400 mg) and will receive 6 cycles of rituximab infused intravenously (IV) ...
... oral chemotherapy regimens. Finally, this study will be the first to track ... The purpose of this study is to evaluate whether the administration of ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.